Related Experiment Video
Updated: Dec 27, 2025

05:46
Application of Laser Microdissection to Uncover Regional Transcriptomics in Human Kidney Tissue
Published on: June 9, 2020
4.3K
Applying single-cell technologies to clinical pathology: progress in nephropathology
Benjamin J Stewart1,2,3, Menna R Clatworthy1,2,3
1Department of Medicine, University of Cambridge, Cambridge, UK.
The Journal of Pathology
|March 4, 2020
Summary
Single-cell technologies offer a powerful new way to understand kidney disease by revealing cell-specific gene expression and epigenetic patterns. This multi-omic approach promises to integrate molecular data with traditional pathology for improved classification and personalized treatments.
Area of Science:
- Cellular biology
- Genomics
- Pathology
Background:
- Accurate characterization of cellular phenotype, intercellular signaling, and spatial organization is crucial for understanding physiology and disease.
- Current nephropathology relies heavily on light microscopy, with bulk transcriptomics offering initial molecular insights.
- Single-cell methodologies are rapidly advancing, providing unprecedented scale and scope for disease research.
Purpose of the Study:
- To review current practices in nephropathology and highlight the potential of single-cell technologies.
- To discuss how single-cell transcriptomics and multi-omic approaches can enhance disease classification and treatment.
- To explore the integration of molecular phenotypes with histopathological descriptions.
Main Methods:
- Review of current nephropathology practices.
- Analysis of bulk transcriptomics studies in kidney disease.
- Exploration of single-cell transcriptomic and epigenetic profiling.
- Discussion of single-cell antigen-receptor gene sequencing.
Main Results:
- Single-cell transcriptomics reveals cell-type-specific gene expression in kidney health and disease.
- These technologies enable interpretation of disease susceptibility genes within specific cell populations.
- Emerging single-cell epigenetic and antigen-receptor sequencing provide deeper molecular insights.
- Multi-omic data holds potential for improved disease classification and personalized medicine.
Conclusions:
- Single-cell technologies are revolutionizing kidney disease research by providing detailed molecular and cellular information.
- Integration of multi-omic data with histopathology will lead to better disease prognostication and tailored treatments.
- The future of nephropathology lies in combining traditional methods with advanced single-cell analyses for personalized patient care.

